1. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
   Changhui Li et al, 2019, Cancer Biol Ther CrossRef
2. Enhancement of Breast Cancer Cell Aggressiveness by lncRNA H19 and its Mir-675 Derivative: Insight into Shared and Different Actions
   Evodie Peperstraete et al, 2020, Cancers CrossRef
3. Comprehensive Analysis of a ceRNA Network Identifies lncR-C3orf35 Associated with Poor Prognosis in Osteosarcoma
   Yi Shi et al, 2020, BioMed Research International CrossRef
4. Inhibition of lncRNA H19/miR-370-3p pathway mitigates neuronal apoptosis in an in vitro model of spinal cord injury (SCI)
   Xin Li et al, 2021 CrossRef
5. Long Noncoding RNA H19: A Novel Therapeutic Target Emerging in Oncology Via Regulating Oncogenic Signaling Pathways
   Baokang Wu et al, 2021, Front. Cell Dev. Biol. CrossRef
6. Recent advances in machine learning methods for predicting LncRNA and disease associations
   Jianjun Tan et al, 2022, Front. Cell. Infect. Microbiol. CrossRef
7. TLR9 Exerts an Oncogenic Role in Promoting Osteosarcoma Progression Depending on the Regulation of NF-κB Signaling Pathway
   Yongbin Jing et al, 2022, Biological & Pharmaceutical Bulletin CrossRef
8. Association of lncRNA H19 polymorphisms with cancer susceptibility: An updated meta-analysis based on 53 studies
   Yingying Yuan et al, 2022, Front. Genet. CrossRef
9. LDA-LNSUBRW: lncRNA-disease association prediction based on linear neighborhood similarity and unbalanced bi-random walk
   Guobo Xie et al, 2020, IEEE/ACM Trans. Comput. Biol. and Bioinf. CrossRef
10. Emerging roles of long non-coding RNAs in osteosarcoma
    Xun Liao et al, 2024, Front. Mol. Biosci. CrossRef